WNT5A was subsequently further investigated for its potential role in the clinical outcome of melanoma, and WNT5A protein expression was shown to predict a shorter recurrence‐free survival in a large cohort of melanoma patients (Da Forno et al., 2008). This evidence concerns the gene WNT5A and melanoma.